IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

The clinical features of EBV-positive diffuse large B cell lymphoma (DLBCL) indicate a poorer prognosis than EBV-negative DLBCL. Currently, there is no efficacious drug for EBV-positive DLBCL. The cytokine interleukin-21 (IL-21) has been reported to be pro-apoptotic in DLBCL cell lines and is being...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxuan, Wang, Chengcheng, Cai, Xiyunyi, Mou, Chang, Cui, Xueting, Zhang, Yingying, Ge, Feng, Dong, Hao, Hao, Yuanyuan, Cai, Lei, Wu, Shuting, Feng, Chenjie, Chen, Jiamin, Li, Jianyong, Xu, Wei, Fan, Lei, Xie, Weijia, Tong, Yue, Gu, Harvest Feng, Wu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378064/
https://www.ncbi.nlm.nih.gov/pubmed/32704112
http://dx.doi.org/10.1038/s41598-020-69227-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378064/
https://www.ncbi.nlm.nih.gov/pubmed/32704112
http://dx.doi.org/10.1038/s41598-020-69227-0

Ejemplares similares